Pyrimethamine Market Key Companies and Analysis Top Trends by 2032

The global pyrimethamine market size was valued at USD 1,000 million in 2021 and is projected to reach around USD 1,650 million in 2030 exhibiting a CAGR of 5.0% in the forecasted period.

The rise in the number of HIV patients across the globe, increasing prevalence of toxoplasmosis infection, growing prevalence of malaria, and surging cancer cases and chemotherapy procedures are anticipated to upsurge the market growth. However, side effects related with pyrimethamine, high cost of pyrimethamine are the factors hindering the growth of the market in the forecasted period.

Toxoplasmosis is an infection produced by a single-celled parasite called Toxoplasma gondii. The increasing prevalence of toxoplasmosis infection is projected to drive the growth of the global pyrimethamine market. According to the sources of the Centers for Disease Control and Prevention (CDC) 2018, in the U.S., a projected 11% of the 6-year-old population was diseased with Toxoplasma gondii. In various places around the world, it is projected that above 60% of people have been affected with Toxoplasma gondii. The infection rate is usually higher in areas with great humidity, heat, and lower altitudes, as oocysts endure better in these types of environments.

Promising side effects related with pyrimethamine contain occasional and probably severe hypersensitivity reactions such as toxic epidermal necrolysis, Stevens-Johnson syndrome, erythema multiforme, and homophenylalanine amines, which are projected to hamper the market growth. Also, the high cost of pyrimethamine is estimated to confine the global pyrimethamine market growth over the forecasted period. For instance, the cost of Daraprim (pyrimethamine) is very high. In 2018, the list price for a one-month stock (60 tablets) in the U.S. was around US$ 45,000.

Since the COVID-19 outbreak in December 2019, the disease has extended to more than 100 nations across the world. The coronavirus (COVID 19) pandemic and following lockdown in several nations across the globe have obstructed the financial status of industries in all sectors. The coronavirus pandemic has also delayed the production, development, and supply of medicines and other healthcare products and affected the growth of the healthcare business of several companies around the world. Hence, during the forecast period, the effect of the COVID19 pandemic is also predicted to hinder the growth of the global pyrimethamine market.

Disease Type Insights
The toxoplasmosis segment led the market for pyrimethamine and accounted for the largest revenue share of around 40% in 2021. Toxoplasmosis is a contamination led by a one-celled organism known as Toxoplasma gondii. The rising frequency of toxoplasmosis inflammation is predicted to fuel the development of the global pyrimethamine market. As per the records of the CDC 2018, in the U.S., nearly 11% of the 6-year-old populace was ill with Toxoplasma gondii. In several areas over the world, it is anticipated that nearly 60% of individuals have been affected with Toxoplasma gondii. The inflammation rate is generally huge in regions with enormous heat, moisture, and less height, as saccule endure best in these forms of surroundings.

Route of Administration Insights
On the basis of route of administration, the market is segmented into oral and parenteral. In 2021, the oral segment ruled the market for pyrimethamine and held the largest market share of 79.0%. The oral segment is made up of small molecule drugs, which are considered the mainstream treatment and they are also simply managed.

Fill Out Details to Receive FREE Sample Report Copy Here:
https://analyticsmarketresearch.com/sample-request/pyrimethamine-market/57611/

Region Insights
North America is expected to dominate the global pyrimethamine market owing to an upsurge in the number of cancer cases (as pyrimethamine can persuade apoptosis of cancer cells) and chemotherapy processes in the region. For instance, as per the 2019-2021 Cancer Survival and Treatment Data and Data Report published by the American Cancer Society, as of January 1, 2019, the projected number of cancer cases in the U.S. was nearly 16,920,370.
However, Asia-Pacific has been observing a positive growth for global pyrimethamine market during the forecasted period owing to augmented government awareness programs, higher prevalence of malaria & AIDS.

Key Companies Insights
The market for pyrimethamine is moderately competitive. With the rising applications of pyrimethamine, new players are considering to enter the market. The companies are also involved in activities like joint ventures, acquisitions, partnerships, mergers, and collaborations. These activities aid in growing the effect of the players in the pyrimethamine market, ultimately boosting the market growth.

Some of the key companies working in the global pyrimethamine market include:
• Vyera Pharmaceuticals, LLC
• Cerovene Healthcare PVT. LTD
• GlaxoSmithKline plc
• Impax Laboratories, Inc.
• NCBO BioPortal
• Pfizer, Inc.
• PRN Pharmacal
• SUDA Pharmaceuticals
• Taj Accura Pharmaceuticals
• TargetMo Chemicals Inc.
• Evaluate Ltd.
• Abcam
• Other players

Segments
By Disease Type
• Toxoplasmosis
• Malaria
• Others

By Route of Administration
• Oral
• Parenteral

By Distribution Channel
• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies

By Geography
• North America
o U.S.
o Canada
o Mexico
• Europe
o U.K.
o Germany
o France
o Italy
o Spain
o Russia
• Asia-Pacific
o Japan
o China
o India
o Australia
o South Korea
o ASEAN
• Latin America
o Brazil
o Argentina
o Colombia
• MEA
o South Africa
o Saudi Arabia
o UAE
o Egypt

Buy Now this Premium Report to Grow your Business:
https://analyticsmarketresearch.com/purchase/pyrimethamine-market/57611/?license=single

Key Benefits
• The study's coverage of industry drivers, restrictions, and opportunities
• neutral view on the state of the market
• recent advancements and trends in the industry
• Competitive environment and important players' plans
• Covered are attractive development locations, potential niche markets, and
• Size of the market in terms of value, past, present, and future
• Analyzing the Container Orchestration Software Market in detail

Reasons to Purchase this Report
• Market segmentation based on qualitative and quantitative analysis, taking into account both economic and non-economic aspects.
• Data on market value (in US dollars) for each section and sub-segment
• Identifies the area and market segment anticipated to experience the quickest growth and hold the majority of the market.
• Analysis by geography showcasing product/service usage in the region and highlighting the market dynamics affecting each region.
• A competitive landscape that takes into account recent service/product launches, collaborations, company expansions, and acquisitions by the companies profiled, as well as the market share of the leading players.
• Comprehensive company profiles for the top players in the industry, including business overviews, corporate insights, product benchmarking, and SWOT analyses
• The industry's future market forecast in light of recent changes, including growth possibilities, drivers of growth, and obstacles present in both developing and emerging economies.
• Comprises a thorough examination of the market from a number of angles using Porter's Five Forces analysis.
• Offers market knowledge across the Value Chain
• The current market dynamics scenario and future market expansion prospects
• Post-sales analyst assistance for six months

For more information about this report visit:-
https://analyticsmarketresearch.com/reports/pyrimethamine-market/57611/

Frequently Asked Questions About This Report
• How big is the Market?
• What is the Market growth?
• Which segment accounted for the largest Market share?
• Who are the key companies/players in the Market?
• What are the factors driving the Market?
• How has the Covid-19 pandemic affected the Market?
• What is the leading solution segment in the Market?
• What is the leading deployment segment in the Market?
• Which enterprise segment accounted for the largest revenue share in the Market?

Contact US:
Analytics Market Research
99 WALL STREET, #2124 NEW YORK, NY 10005
Phone: +1(650)-666-4592
Email: sales@analyticsmarketresearch.com
Visit Our More Blog:- https://www.linkedin.com/company/analytics-market-research/

About US:
Analytics Market Research is an established market analytics and research firm with a domain experience sprawling across different industries. We have been working on multi-county market studies right from our inception. Over the time, from our existence, we have gained laurels for our deep rooted market studies and insightful analysis of different markets.

Our strategic market analysis and capability to comprehend deep cultural, conceptual and social aspects of various tangled markets has helped us make a mark for ourselves in the industry. Analytics Market Research is a frontrunner in helping numerous companies; both regional and international to successfully achieve their business goals based on our in-depth market analysis. Moreover, we are also capable of devising market strategies that ensure guaranteed customer bases for our clients.

This release was published on openPR.